Remed issues ₩10.0bn convertible bonds maturing Nov 4, 2031
Remed filed for ₩10.0bn in convertible bonds with a 1.0% coupon, maturing Nov 4, 2031. The conversion price is ₩2,774, and conversion could issue 3,604,902 shares, or 11.9% of total shares. The face amount is 40.8% of FY2025 revenue by our calculation.
Key facts
| Face amount | ₩10.0bn |
|---|---|
| Conversion price | ₩2,774 |
| Shares issuable on conversion | 3,604,902 shares |
| % of total shares | 11.9% |
| Maturity date | Nov 4, 2031 |
| Coupon rate | 1.0% |
Comparison
| Amount as % of FY2025 revenue (calculated) | 40.8% |
|---|---|
| Revenue 2025 | ₩24.5bn |
| Revenue 2024 | ₩25.6bn |
| Revenue 2023 | ₩18.5bn |
Context
In the 12 months before this filing, insiders made net open-market purchases of 12,000 shares.
Key metrics
Potential dilution
| CB/BW/EB issued, last 12 months | ₩10.0bn |
|---|---|
| Rights offering new shares, last 12 months | 0 shares |
| Potential new shares, last 12 months | 3,604,902 shares |
| Potential new shares, % of shares | 11.9% |
| Conversion price adjustments, last 12 months | 0 |
Source: DART (Financial Supervisory Service) · Original filing on DART ↗